BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28340041)

  • 1. Bleeding Complications in Patients Undergoing Intrathecal Drug Delivery System Implantation.
    Warner NS; Bendel MA; Warner MA; Strand JJ; Gazelka HM; Hoelzer BC; Mauck WD; Lamer TJ; Kor DJ; Moeschler SM
    Pain Med; 2017 Dec; 18(12):2422-2427. PubMed ID: 28340041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding Complications in Patients Undergoing Celiac Plexus Block.
    Warner NS; Moeschler SM; Warner MA; Hoelzer BC; Eldrige JS; Bendel MA; Mauck WD; Watson JC; Gazelka HM; Lamer TJ; Kor DJ; Hooten WM
    Reg Anesth Pain Med; 2016; 41(4):488-93. PubMed ID: 27203395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding and Neurologic Complications in 58,000 Interventional Pain Procedures.
    Warner NS; Hooten WM; Warner MA; Lamer TJ; Eldrige JS; Gazelka HM; Kor DJ; Hoelzer BC; Mauck WD; Moeschler SM
    Reg Anesth Pain Med; 2017; 42(6):782-787. PubMed ID: 29016553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bleeding Complications in Patients Undergoing Percutaneous Spinal Cord Stimulator Trials and Implantations.
    Moeschler SM; Warner NS; Lamer TJ; Bendel MA; Warner MA; Eldrige JS; Mauck WD; Gazelka HM; Kor DJ; Hoelzer BC
    Pain Med; 2016 Nov; 17(11):2076-2081. PubMed ID: 27296055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Kaye AD; Manchikanti L; Novitch MB; Mungrue IN; Anwar M; Jones MR; Helander EM; Cornett EM; Eng MR; Grider JS; Harned ME; Benyamin RM; Swicegood JR; Simopoulos TT; Abdi S; Urman RD; Deer TR; Bakhit C; Sanapati M; Atluri S; Pasupuleti R; Soin A; Diwan S; Vallejo R; Candido KD; Knezevic NN; Beall D; Albers SL; Latchaw RE; Prabhakar H; Hirsch JA
    Pain Physician; 2019 Jan; 22(1S):S75-S128. PubMed ID: 30717501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Site Infections in Cancer Patients with Intrathecal Drug Delivery Devices.
    Scanlon MM; Gazelka HM; Moeschler SM; Hoelzer BC; Hooten WM; Bendel MA; Lamer TJ
    Pain Med; 2017 Mar; 18(3):520-525. PubMed ID: 27550951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients.
    Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N
    Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of eptifibatide as a bridge antiplatelet agent for intrathecal drug delivery system placement.
    Sisk J; Palma M; Cooper C; Eltahawy E; Atallah J
    Pain Physician; 2012; 15(6):479-83. PubMed ID: 23159964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopenia.
    Napolitano G; Iacobellis A; Merla A; Niro G; Valvano MR; Terracciano F; Siena D; Caruso M; Ippolito A; Mannuccio PM; Andriulli A
    Eur J Intern Med; 2017 Mar; 38():79-82. PubMed ID: 27989373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.
    Stearns LM; Abd-Elsayed A; Perruchoud C; Spencer R; Hammond K; Stromberg K; Weaver T
    Anesth Analg; 2020 Feb; 130(2):289-297. PubMed ID: 31567325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of practice patterns of perioperative management of antiplatelet and anticoagulant therapy in interventional pain management.
    Manchikanti L; Benyamin RM; Swicegood JR; Falco FJ; Datta S; Pampati V; Fellows B; Hirsch JA
    Pain Physician; 2012; 15(6):E955-68. PubMed ID: 23159981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Discontinuation of Systemic Opioids After Implantation of an Intrathecal Drug Delivery System.
    Caraway D; Walker V; Becker L; Hinnenthal J
    Neuromodulation; 2015 Aug; 18(6):508-15; discussion 515-6. PubMed ID: 26053626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper Antero-Medial Thigh as an Alternative Site for Implantation of Intrathecal Pumps: A Case Series.
    Narang S; Srinivasan SK; Zinboonyahgoon N; Sampson CE
    Neuromodulation; 2016 Aug; 19(6):655-63. PubMed ID: 27388670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Contemporary Medicolegal Analysis of Implanted Devices for Chronic Pain Management.
    Abrecht CR; Greenberg P; Song E; Urman RD; Rathmell JP
    Anesth Analg; 2017 Apr; 124(4):1304-1310. PubMed ID: 28319551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function.
    Odell DW; Albrechtsen RD; Sindt JE; Gole R; Brown S; Parsons MW; Paxton AB; Sarkar V; Lloyd S; Brogan SE; Tao R
    Neuromodulation; 2021 Oct; 24(7):1204-1208. PubMed ID: 33624320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.